Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 32.70B | 32.86B | 33.10B | 32.36B | 24.44B |
Gross Profit | 5.45B | 5.32B | 4.42B | 5.88B | 4.56B |
EBITDA | 1.56B | 1.31B | 532.00M | 1.78B | 1.35B |
Net Income | 522.00M | 220.00M | -444.00M | 811.00M | 501.00M |
Balance Sheet | |||||
Total Assets | 37.52B | 40.11B | 38.55B | 40.09B | 35.89B |
Cash, Cash Equivalents and Short-Term Investments | 2.94B | 3.82B | 2.96B | 3.50B | 3.15B |
Total Debt | 7.13B | 7.58B | 10.16B | 9.96B | 8.91B |
Total Liabilities | 18.52B | 21.64B | 21.60B | 23.09B | 19.67B |
Stockholders Equity | 17.79B | 17.29B | 15.86B | 15.94B | 15.21B |
Cash Flow | |||||
Free Cash Flow | -889.00M | 2.80B | -593.00M | -705.00M | -680.00M |
Operating Cash Flow | -224.00M | 3.58B | 104.00M | 1.08B | 1.25B |
Investing Cash Flow | -174.00M | -60.00M | -659.00M | -1.60B | -1.71B |
Financing Cash Flow | -513.00M | -2.60B | -3.00M | 861.00M | 519.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥7.09B | 12.06 | 2.57% | 6.93% | -6.22% | ||
76 Outperform | ¥9.09B | 6.20 | 1.36% | 10.66% | 69.54% | ||
74 Outperform | ¥24.74B | 7.58 | 4.41% | 9.75% | 28.00% | ||
74 Outperform | ¥17.32B | 11.07 | 2.46% | 5.96% | 182.60% | ||
71 Outperform | ¥18.93B | 7.40 | 3.77% | 0.79% | 60.97% | ||
68 Neutral | ¥8.24B | 15.78 | 1.42% | -0.49% | 137.27% | ||
44 Neutral | C$842.44M | -6.68 | -16.47% | 2.82% | 16.34% | -27.11% |